Interview with German Knop V., General Manager and CEO, Knop Chile
The Bayer Schering merger in 2006 saw you add Argentina and Bolivia to your existing main milestones and achievements of the company since you have been at the head? My…
Address: Avenida Industrial’ 1198, Quilpué,Chile
Tel: +56 32 294 5964
Web: http://www.knop.cl/empresa/index.html
Knop is a company dedicated entirely to producing homeopathic and providing natural healthcare solutions. It initiated its operations in 1931 as a pharmacy in Valparaiso. The company began producing homeopathic treatments in 1955. The vision behind the company was to incorporate homeopathic and phytopathic treatments as a valid tool to an improved healthcare and lifestyle. They distinguish themselves as a company committed to quality and the improvement of their processes and R&D to be able to bring to the market innovative products produced entirely by then and backed by scientific data. All of the active ingredients used in their products are 100% natural and most of them are produced by the company itself.
homeopathic and phytotherapeutic products
The Bayer Schering merger in 2006 saw you add Argentina and Bolivia to your existing main milestones and achievements of the company since you have been at the head? My…
Eduardo Loyola has been at the helm of Heel’s Chilean affiliate for almost a decade. Prior to his appointment at Heel, Loyola was part of a working group that is…
Medtronic, world’s largest medical technology company, opened a direct operation in Chile in October 2013. Gonzalo Valdebenito elaborates on the affiliate’s first steps in the country and the mission he…
Cells for Cells is the first Chilean biotechnology company engaged in the research, development and commercialization of innovative cell therapies based on adult stem cells. In line with the company’s…
“We have implemented a strategic plan with a key objective to put Chile on the map. We are seeing major market opportunities in the country”, says Carlos Cicogna, Managing Director,…
Ciro Caravaggio, General Manager at Roche Chile discusses Roche’s mission as a highly specialized biotech with a long presence in Chile. He stresses the importance of the affiliate’s role in…
Raúl Sánchez, general manager of Peri Logistics speaks about the main features that distinguish Peri Logistics as a pharmaceutical logistics operator. Celebrating its 10th year anniversary this year, the company…
João Simões, Head of Integration at Grunenthal Chile, discusses Grunenthal’s acquisition of Andrómaco Laboratories. The acquisition has been a major step in Grunenthal’s growth strategy and has almost doubled its…
“70 percent of products on the Chilean market cannot demonstrate quality, safety and efficacy through bioequivalence studies”, explains Jean Jacques Duhart, Vicepresidente Ejecutivo of the association that represents the innovative…
Rodrigo Azócar Ibaceta, general manager at Laboratorios Raffo Chile speaks about Raffo’s development on the Chilean market. Part of the prestigious GP Pharm’s group, Raffo is one of the fastest…
Erich Viertel Molina, country manager at Janssen Chile speaks about Janssen’s commitment to the health of Chileans. Over the past years Janssen successfully launched several products to the Chilean market…
Pfizer will invest in a precision medical center studying new genome-based diagnostic technologies for cancer in Chile. It is the first center of excellence that Pfizer is building in Chile…
Our business model is new in the Chilean market and enables us with great flexibility and allows us to focus on demand generation. For Ferrer this is a great window…
See our Cookie Privacy Policy Here